Don't forget Rachel McMinn lowered to $27M in Dec...
"...looking for slow initial Iclusig launch...We model $27M in 2013 US Iclusig sales, well below the company's soft guidance of <$50M and consensus of $49M. Our analysis shows consensus implies Iclusig outperforms the Tasigna US launch by 25%+"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.